Jade Biosciences, Inc.
General ticker "JBIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $34.6M (TTM average)
Jade Biosciences, Inc. does not follow the US Stock Market performance with the rate: -32.9%.
Estimated limits based on current volatility of 4.6%: low 13.34$, high 14.46$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-04-25, amount 2.40$ (Y16.17%)
Short-term JBIO quotes
Long-term JBIO plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $53.24MM | $81.41MM | $74.60MM |
| Operating Income | $-53.24MM | $-81.41MM | $-74.60MM |
| Non-Operating Income | $1.75MM | $5.94MM | $5.02MM |
| R&D Expense | $38.62MM | $64.22MM | $53.19MM |
| Income(Loss) | $-51.49MM | $-75.47MM | $-69.57MM |
| Taxes | $0.03MM | $0.06MM | $0.06MM |
| Profit(Loss)* | $-51.51MM | $-75.52MM | $-69.63MM |
| Stockholders Equity | $126.74MM | $109.46MM | $76.43MM |
| Assets | $135.30MM | $127.42MM | $80.33MM |
| Operating Cash Flow | $-39.12MM | $-56.78MM | $-71.20MM |
| Capital expenditure | $0.20MM | $0.14MM | $0.00MM |
| Investing Cash Flow | $6.93MM | $11.88MM | $56.03MM |
| Financing Cash Flow | $0.40MM | $46.00MM | $25.43MM |
| Earnings Per Share** | $-73.67 | $-100.38 | $-85.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.